AR023625A1 - Compuestos no estequiometricos formados entre primicina y ciclodextrina - Google Patents
Compuestos no estequiometricos formados entre primicina y ciclodextrinaInfo
- Publication number
- AR023625A1 AR023625A1 ARP970101304A ARP970101304A AR023625A1 AR 023625 A1 AR023625 A1 AR 023625A1 AR P970101304 A ARP970101304 A AR P970101304A AR P970101304 A ARP970101304 A AR P970101304A AR 023625 A1 AR023625 A1 AR 023625A1
- Authority
- AR
- Argentina
- Prior art keywords
- primicin
- primicine
- estequiometric
- cyclodextrine
- compounds formed
- Prior art date
Links
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title abstract 3
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9600847A HUP9600847A3 (en) | 1996-04-02 | 1996-04-02 | Nonstochiometric compds. of primycins with ciclodextrin derivatives, pharmaceutical compns. contg. the said compds. and process for preparing them |
Publications (1)
Publication Number | Publication Date |
---|---|
AR023625A1 true AR023625A1 (es) | 2002-09-04 |
Family
ID=89993853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970101304A AR023625A1 (es) | 1996-04-02 | 1997-04-02 | Compuestos no estequiometricos formados entre primicina y ciclodextrina |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR023625A1 (hu) |
AU (1) | AU2173297A (hu) |
HU (1) | HUP9600847A3 (hu) |
WO (1) | WO1997036935A1 (hu) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1918700A (en) * | 1998-11-23 | 2000-06-13 | Procter & Gamble Company, The | Skin deodorizing and sanitizing compositions |
PE20020300A1 (es) | 2000-08-22 | 2002-05-10 | Pharmacia Corp | Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco |
US20060257488A1 (en) * | 2005-05-10 | 2006-11-16 | Cytophil, Inc. | Injectable hydrogels and methods of making and using same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU196822B (en) * | 1984-07-03 | 1989-01-30 | Chinoin Gyogyszer Es Vegyeszet | Process for producing primicin salts |
-
1996
- 1996-04-02 HU HU9600847A patent/HUP9600847A3/hu unknown
-
1997
- 1997-03-28 WO PCT/HU1997/000010 patent/WO1997036935A1/en active Application Filing
- 1997-03-28 AU AU21732/97A patent/AU2173297A/en not_active Abandoned
- 1997-04-02 AR ARP970101304A patent/AR023625A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
HU9600847D0 (en) | 1996-05-28 |
HUP9600847A2 (hu) | 1998-01-28 |
AU2173297A (en) | 1997-10-22 |
WO1997036935A1 (en) | 1997-10-09 |
HUP9600847A3 (en) | 1999-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2176206T3 (es) | Derivados de ciclodextrinas que muestran solubilidad incrementada en el agua y utilizacion de los mismos. | |
PT1413582E (pt) | Pirrolobenzodiazepinas dimericas | |
FI931250A (fi) | Sulfonamido- och sulfonamidokarbonyl-pyridin-2-karboxylsyraamider och deras pyridin-n-oxider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel | |
DE3761562D1 (de) | Taxal-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
ATE233274T1 (de) | Oxyiminopregnancarbolactone | |
CA2074186A1 (en) | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof | |
ES2090713T3 (es) | Sales organicas de n,n'-diacetil-cistina. | |
AR024839A1 (es) | Compuesto bi o triciclico sustituido, su uso en la fabricacion de un medicamento y composicion farmaceutica que lo comprende. | |
ES2094694B1 (es) | Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion. | |
MX9205544A (es) | Particularidad de bombeo en manguito de desgaste para sello unificado. | |
PE20010053A1 (es) | Formulacion de amoxicilina y clavulanato de potasio | |
GT199900180AA (es) | Composicion farmacéutica para ser aplicada a las mucosas . | |
CO5231147A1 (es) | Composicion congelante | |
SE8200171L (sv) | 3-aminopropoxiaryl-derivat, framstellning derav och lekemedel innehallande dessa | |
ES2192680T3 (es) | Nuevos derivados de vitamina d con sustituyentes carbo- o heterociclicos en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos. | |
ATE308552T1 (de) | Makrolide mit entzündungshemmender wirkung | |
IT1269578B (it) | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base. | |
AR023625A1 (es) | Compuestos no estequiometricos formados entre primicina y ciclodextrina | |
IT1248475B (it) | Composti di inclusione di nimesulide con ciclodestrine | |
ES2166900T3 (es) | Derivados de ara-c. | |
ES2193007T1 (es) | Formulacion farmaceutica estable que comprende la modificacion ii de torsemida. | |
ES2054654T3 (es) | Derivados farmaceuticamente utiles de acido tiazolidina-4-carboxilico. | |
AR023668A1 (es) | Nuevos derivados de benzoilguanidina con ventajosas propiedades, procedimiento para su preparacion y su utilizacion en la preparacion de medicamentos | |
ITMI920084A1 (it) | Alchil derivati del trazodone | |
FI934468A0 (fi) | Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytesmellanprodukter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |